Harrow HROW Compounding — Cost of Goods Sold

Other segment segments

Similar metrics at other companies

LQD

LQDAProduct — Cost of Goods Sold

$11.08M—

NEOGProduct — Cost of Goods Sold

$96M+0.2%

AIRProduct — Cost of Goods Sold

$440.2M+32.6%

SEBProduct — Cost of Goods Sold

$1.76B-2.3%

ACLSProduct — Cost of Goods Sold

$105.74M+11.9%

OSISProduct — Cost of Goods Sold

$242.57M+2.5%

Questions, answered.

What is Harrow's compounding — cost of goods sold?

Harrow (HROW) reported compounding — cost of goods sold of $6.2M in Q1 2026.

How has Harrow's compounding — cost of goods sold changed year-over-year?

Harrow's compounding — cost of goods sold decreased by 15.5% year-over-year, from $7.34M to $6.2M.

What does compounding — cost of goods sold mean?

This metric captures the direct costs associated with the production and delivery of compounded pharmaceutical products, including raw materials, labor, and manufacturing overhead. It is a critical measure of production efficiency and supply chain management for the compounding segment. Monitoring these costs is essential for understanding the segment's ability to maintain margins amidst fluctuations in input prices.